Bernardino, Jose I

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. [electronic resource] - The lancet. HIV Nov 2015 - e464-73 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2352-3018

10.1016/S2352-3018(15)00181-2 doi


Absorptiometry, Photon
Adult
Anti-HIV Agents--administration & dosage
Biomarkers--blood
Bone Density--drug effects
Bone Diseases, Metabolic--chemically induced
CD4 Lymphocyte Count
Comorbidity
Darunavir--administration & dosage
Drug Therapy, Combination
Emtricitabine--administration & dosage
Europe--epidemiology
Female
HIV Infections--complications
Humans
Inflammation--physiopathology
Male
Middle Aged
Osteopetrosis--chemically induced
Raltegravir Potassium--administration & dosage
Ritonavir--administration & dosage
Tenofovir--administration & dosage
Viral Load